
Cognition Therapeutics Publishes Proteomic Analysis Elucidating Zervimesine's Protection Of Neurons And Synapses In ...
(MENAFN- GlobeNewsWire - Nasdaq) In Vitro Experiments Showing Protection of Neurons under Disease Conditions Support Proteomics Biomarker Analysis from Phase 2 SEQUEL Study PITTSBURGH, July 21, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , (the“ …